Rajdeep Banerjee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rajdeep Banerjee has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Betül Kaçar
Department of Bacteriology, University of Wisconsin-Madison, Madison, USA
2 shared publications - Elias I. Kemna
Department of Plant and Microbial Biology, University of Minnesota
1 shared publication - Evrim Fer
Department of Bacteriology, University of Wisconsin-Madison, Madison, USA
1 shared publication - Kaitlyn M. McGrath
Department of Bacteriology, University of Wisconsin-Madison, Madison, WI, USA
1 shared publication - Katsumi Hagino
Department of Bacteriology, University of Wisconsin-Madison, Madison, WI, USA
1 shared publication
Latest Publications
- Open Access
Evolution-guided engineering of an ancient nitrogenase interface enhances enzyme activity and stability
Nitrogenase is essential for biological nitrogen fixation and a key target for improving sustainable agriculture. The structural and functional complexity of nitrogenase makes it difficult to identify regions that can be engineered without disrupting activity, stability, or complex assembly. To address this challenge, we used an evolution-guided approach to identify lineage-specific regions with potential engineering tolerance, revealing a NifK N-terminal extension as a tunable interface. By generating variant libraries exceeding 9,000 members and evaluating them through diazotrophic growth assays and in-vitro characterization, we show that NifK extension is required for nitrogenase activity while remaining broadly tolerant to mutation, revealing a sequence-function landscape that is both flexible and constrained. A subset of residues at the NifD-NifK interface are critical for maintaining complex stability. Structural analyses indicate that the extension stabilizes the MoFe complex via co-evolved electrostatic interactions, and targeted mutations can improve both enzymatic activity and thermostability. These findings identify the NifK extension as a tunable interface, providing a strategy for engineering more robust nitrogenase variants.
Open AccessEvolution-guided engineering of an ancient nitrogenase interface enhances enzyme activity and stability
Nitrogenase is essential for biological nitrogen fixation and a key target for improving sustainable agriculture. The structural and functional complexity of nitrogenase makes it difficult to identify regions that can be engineered without disrupting activity, stability, or complex assembly. To address this challenge, we used an evolution-guided approach to identify lineage-specific regions with potential engineering tolerance, revealing a NifK N-terminal extension as a tunable interface. By generating variant libraries exceeding 9,000 members and evaluating them through diazotrophic growth assays and in-vitro characterization, we show that NifK extension is required for nitrogenase activity while remaining broadly tolerant to mutation, revealing a sequence-function landscape that is both flexible and constrained. A subset of residues at the NifD-NifK interface are critical for maintaining complex stability. Structural analyses indicate that the extension stabilizes the MoFe complex via co-evolved electrostatic interactions, and targeted mutations can improve both enzymatic activity and thermostability. These findings identify the NifK extension as a tunable interface, providing a strategy for engineering more robust nitrogenase variants.
- Open Access
Evolution of Translation Initiation Factor 2 Extensions Links Initiation to Bacterial Stress Response
Terminal extensions are recurrent features in protein evolution, often linked to environmental adaptation and novel regulatory or interaction functions. Here, we combine comparative genomics, structural modeling, and functional assays to elucidate the evolutionary diversification and functional significance of one of the key proteins of all cells, translation initiation factor 2 (IF2) terminal extensions across the tree of life. Specifically, we reconstruct the first comprehensive evolutionary map of IF2 across life, analyzing ∼800 homologs and classify seven distinct structural architectures of IF2 based on extension regions. These extensions are enriched for intrinsically disordered and phase-separation–promoting residues, suggesting roles beyond the conserved catalytic core. Further, functional characterization of IF2 with varying N-terminal lengths show that loss of the N-terminal extension slows bacterial growth specifically under temperature and pH stress. Appending C-terminal extensions from different organisms to the Escherichia coli IF2 demonstrates a conserved role for these extensions in adaptation to temperature and anaerobiosis. Our findings establish the functional significance of IF2 terminal extensions, linking their evolutionary diversification to stress-dependent regulation of translation.
Open AccessEvolution of Translation Initiation Factor 2 Extensions Links Initiation to Bacterial Stress Response
Terminal extensions are recurrent features in protein evolution, often linked to environmental adaptation and novel regulatory or interaction functions. Here, we combine comparative genomics, structural modeling, and functional assays to elucidate the evolutionary diversification and functional significance of one of the key proteins of all cells, translation initiation factor 2 (IF2) terminal extensions across the tree of life. Specifically, we reconstruct the first comprehensive evolutionary map of IF2 across life, analyzing ∼800 homologs and classify seven distinct structural architectures of IF2 based on extension regions. These extensions are enriched for intrinsically disordered and phase-separation–promoting residues, suggesting roles beyond the conserved catalytic core. Further, functional characterization of IF2 with varying N-terminal lengths show that loss of the N-terminal extension slows bacterial growth specifically under temperature and pH stress. Appending C-terminal extensions from different organisms to the Escherichia coli IF2 demonstrates a conserved role for these extensions in adaptation to temperature and anaerobiosis. Our findings establish the functional significance of IF2 terminal extensions, linking their evolutionary diversification to stress-dependent regulation of translation.
- Open Access
- 5 May 2025
- Published by MDPI AG in Non-Coding RNA
- Vol. 11 (3) , 36
Tiny but Mighty: Small RNAs—The Micromanagers of Bacterial Survival, Virulence, and Host–Pathogen Interactions
Bacterial pathogens have evolved diverse strategies to infect hosts, evade immune responses, and establish successful infections. While the role of transcription factors in bacterial virulence is well documented, emerging evidence highlights the significant contribution of small regulatory RNAs (sRNAs) in bacterial pathogenesis. These sRNAs function as posttranscriptional regulators that fine-tune gene expression, enabling bacteria to adapt rapidly to challenging environments. This review explores the multifaceted roles of bacterial sRNAs in host–pathogen interactions. Firstly, it examines how sRNAs regulate pathogenicity by modulating the expression of key virulence factors, including fimbriae, toxins, and secretion systems, followed by discussing the role of sRNAs in bacterial stress response mechanisms that counteract host immune defenses, such as oxidative and envelope stress. Additionally, this review investigates the involvement of sRNAs in antibiotic resistance by regulating efflux pumps, biofilm formation, and membrane modifications, which contribute to multi-drug resistance phenotypes. Lastly, this review highlights how sRNAs contribute to intra- and interspecies communication through quorum sensing, thereby coordinating bacterial behavior in response to environmental cues. Understanding these regulatory networks governed by sRNAs is essential for the development of innovative antimicrobial strategies. This review highlights the growing significance of sRNAs in bacterial pathogenicity and explores their potential as therapeutic targets for the treatment of bacterial infections.
- 5 May 2025
- Published by MDPI AG in Non-Coding RNA
- Vol. 11 (3) , 36
Open AccessTiny but Mighty: Small RNAs—The Micromanagers of Bacterial Survival, Virulence, and Host–Pathogen Interactions
Bacterial pathogens have evolved diverse strategies to infect hosts, evade immune responses, and establish successful infections. While the role of transcription factors in bacterial virulence is well documented, emerging evidence highlights the significant contribution of small regulatory RNAs (sRNAs) in bacterial pathogenesis. These sRNAs function as posttranscriptional regulators that fine-tune gene expression, enabling bacteria to adapt rapidly to challenging environments. This review explores the multifaceted roles of bacterial sRNAs in host–pathogen interactions. Firstly, it examines how sRNAs regulate pathogenicity by modulating the expression of key virulence factors, including fimbriae, toxins, and secretion systems, followed by discussing the role of sRNAs in bacterial stress response mechanisms that counteract host immune defenses, such as oxidative and envelope stress. Additionally, this review investigates the involvement of sRNAs in antibiotic resistance by regulating efflux pumps, biofilm formation, and membrane modifications, which contribute to multi-drug resistance phenotypes. Lastly, this review highlights how sRNAs contribute to intra- and interspecies communication through quorum sensing, thereby coordinating bacterial behavior in response to environmental cues. Understanding these regulatory networks governed by sRNAs is essential for the development of innovative antimicrobial strategies. This review highlights the growing significance of sRNAs in bacterial pathogenicity and explores their potential as therapeutic targets for the treatment of bacterial infections.
- Open Access
- 4 March 2025
- Published by MDPI AG in Preprints.org
Tiny But Mighty: Small RNAs-the Micromanagers of Bacterial Survival, Virulence and Host-Pathogen Interactions
Bacterial pathogens have evolved diverse strategies to infect hosts, evade immune responses, and establish successful infections. While the role of transcription factors in bacterial virulence is well-documented, emerging evidence highlights the significant contribution of small regulatory RNAs (sRNAs) in bacterial pathogenesis. These sRNAs function as post-transcriptional regulators that fine-tune gene expression, enabling bacteria to adapt rapidly to challenging environments. This review explores the multifaceted roles of bacterial sRNAs in host-pathogen interactions. Firstly, it examines how sRNAs regulate virulence by modulating the expression of key virulence factors, including fimbriae, toxins, and secretion systems followed by discussing the role of sRNAs in bacterial stress response mechanisms that counteract host immune defenses, such as oxidative and envelope stress resistance pathways. Additionally, this review investigates the involvement of sRNAs in antibiotic resistance by regulating efflux pumps, biofilm formation, and target modifications, which contribute to multidrug resistance phenotypes. Lastly, this review highlights how sRNAs contribute to intra- and inter-species communication through quorum sensing, thereby coordinating bacterial behavior in response to environmental cues. Understanding these regulatory networks governed by small RNAs (sRNAs) is essential for the development of innovative antimicrobial strategies. This review highlights the growing significance of sRNAs in bacterial pathogenicity and explores their potential as therapeutic targets for the treatment of bacterial infections.
- 4 March 2025
- Published by MDPI AG in Preprints.org
Open AccessTiny But Mighty: Small RNAs-the Micromanagers of Bacterial Survival, Virulence and Host-Pathogen Interactions
Bacterial pathogens have evolved diverse strategies to infect hosts, evade immune responses, and establish successful infections. While the role of transcription factors in bacterial virulence is well-documented, emerging evidence highlights the significant contribution of small regulatory RNAs (sRNAs) in bacterial pathogenesis. These sRNAs function as post-transcriptional regulators that fine-tune gene expression, enabling bacteria to adapt rapidly to challenging environments. This review explores the multifaceted roles of bacterial sRNAs in host-pathogen interactions. Firstly, it examines how sRNAs regulate virulence by modulating the expression of key virulence factors, including fimbriae, toxins, and secretion systems followed by discussing the role of sRNAs in bacterial stress response mechanisms that counteract host immune defenses, such as oxidative and envelope stress resistance pathways. Additionally, this review investigates the involvement of sRNAs in antibiotic resistance by regulating efflux pumps, biofilm formation, and target modifications, which contribute to multidrug resistance phenotypes. Lastly, this review highlights how sRNAs contribute to intra- and inter-species communication through quorum sensing, thereby coordinating bacterial behavior in response to environmental cues. Understanding these regulatory networks governed by small RNAs (sRNAs) is essential for the development of innovative antimicrobial strategies. This review highlights the growing significance of sRNAs in bacterial pathogenicity and explores their potential as therapeutic targets for the treatment of bacterial infections.
- Open Access
Synthetic Biology-Based Approaches to Investigate Host–Pathogen Interactions
The increasing prevalence of multi-drug-resistant (MDR) bacterial pathogens presents a critical global health threat, highlighting the urgent need for innovative approaches to understanding bacterial pathogenesis and developing effective therapies. This review underscores the potential of synthetic biology in elucidating host–pathogen interactions and facilitating the creation of advanced diagnostic tools and targeted therapies to combat MDR infections. We first explore CRISPR-based strategies that modulate essential gene expression, providing insights into the molecular mechanisms underlying host–pathogen interactions. Next, we discuss engineered microbial synthetic circuits for rapid pathogen detection by identifying molecular signatures involved in interspecies communication and facilitating swift pathogen elimination. Additionally, we explore phage therapy (PT), which leverages bacteriophages to selectively target and eliminate specific bacterial pathogens, presenting a targeted and promising approach to combat MDR infections. Finally, we review the application of organ-on-a-chip (OOAC) technology, which overcomes the limitations of animal models in predicting human immune responses by using microfluidic devices that simulate organ-level physiology and pathophysiology, thereby enabling more accurate disease modeling, drug testing, and the development of personalized medicine. Collectively, these synthetic biology tools provide transformative insights into the molecular mechanisms of host–pathogen interactions, advancing the development of precise diagnostic and therapeutic strategies against MDR infections.
Open AccessSynthetic Biology-Based Approaches to Investigate Host–Pathogen Interactions
The increasing prevalence of multi-drug-resistant (MDR) bacterial pathogens presents a critical global health threat, highlighting the urgent need for innovative approaches to understanding bacterial pathogenesis and developing effective therapies. This review underscores the potential of synthetic biology in elucidating host–pathogen interactions and facilitating the creation of advanced diagnostic tools and targeted therapies to combat MDR infections. We first explore CRISPR-based strategies that modulate essential gene expression, providing insights into the molecular mechanisms underlying host–pathogen interactions. Next, we discuss engineered microbial synthetic circuits for rapid pathogen detection by identifying molecular signatures involved in interspecies communication and facilitating swift pathogen elimination. Additionally, we explore phage therapy (PT), which leverages bacteriophages to selectively target and eliminate specific bacterial pathogens, presenting a targeted and promising approach to combat MDR infections. Finally, we review the application of organ-on-a-chip (OOAC) technology, which overcomes the limitations of animal models in predicting human immune responses by using microfluidic devices that simulate organ-level physiology and pathophysiology, thereby enabling more accurate disease modeling, drug testing, and the development of personalized medicine. Collectively, these synthetic biology tools provide transformative insights into the molecular mechanisms of host–pathogen interactions, advancing the development of precise diagnostic and therapeutic strategies against MDR infections.
- Open Access
- 17 December 2024
- Published by MDPI AG in Preprints.org
Synthetic Biology-Based Approaches to Probe Host-Pathogen Interactions
The increasing prevalence of multi-drug-resistant (MDR) bacterial pathogens presents a critical global health threat, highlighting the urgent need for innovative approaches to understanding bacterial patho-genesis and developing effective therapies. This review explores the potential of synthetic biology as a promising tool for investigating host-pathogen interactions and offering alternative therapeutic solu-tions for MDR infections. We first examine the progress of CRISPR-based strategies that have enabled modulation of essential gene expression, providing insights into the molecular mechanisms underly-ing host-pathogen interactions. We then discuss the use of engineered microbial synthetic circuits for rapid pathogen detection, which identify molecular signatures involved in interspecies communica-tion and facilitate swift pathogen elimination. Additionally, we explore the potential of Phage Therapy (PT), which leverages bacteriophages to selectively target and eliminate specific bacterial pathogens, presenting a targeted and promising approach to combat MDR infections. Finally, we review the appli-cation of Organ-On-A-Chip (OOAC) technology, which overcomes the limitations of animal models in predicting human immune responses by using microfluidic devices that simulate organ-level physi-ology and pathophysiology, thereby enabling more accurate disease modeling, drug testing, and the development of personalized medicine.
- 17 December 2024
- Published by MDPI AG in Preprints.org
Open AccessSynthetic Biology-Based Approaches to Probe Host-Pathogen Interactions
The increasing prevalence of multi-drug-resistant (MDR) bacterial pathogens presents a critical global health threat, highlighting the urgent need for innovative approaches to understanding bacterial patho-genesis and developing effective therapies. This review explores the potential of synthetic biology as a promising tool for investigating host-pathogen interactions and offering alternative therapeutic solu-tions for MDR infections. We first examine the progress of CRISPR-based strategies that have enabled modulation of essential gene expression, providing insights into the molecular mechanisms underly-ing host-pathogen interactions. We then discuss the use of engineered microbial synthetic circuits for rapid pathogen detection, which identify molecular signatures involved in interspecies communica-tion and facilitate swift pathogen elimination. Additionally, we explore the potential of Phage Therapy (PT), which leverages bacteriophages to selectively target and eliminate specific bacterial pathogens, presenting a targeted and promising approach to combat MDR infections. Finally, we review the appli-cation of Organ-On-A-Chip (OOAC) technology, which overcomes the limitations of animal models in predicting human immune responses by using microfluidic devices that simulate organ-level physi-ology and pathophysiology, thereby enabling more accurate disease modeling, drug testing, and the development of personalized medicine.